mibefradil has been researched along with Nerve Pain in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 12 (92.31) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Back, SK; Choo, HY; Kam, YL; Na, HS; Rhee, HK; Rhim, H | 1 |
| Chung, HJ; Lee, YS; Pae, AN; Roh, EJ; Seo, SH; Shin, KJ; Song, CM; Woo, HM | 1 |
| Chung, H; Keum, G; Kim, JH; Nam, G | 1 |
| Kim, JH; Nam, G | 1 |
| Du Nguyen, H; Horaguchi, Y; Kasanami, Y; Kawabata, A; Kitamura, S; Nishikawa, H; Okada, T; Sekiguchi, F; Toyooka, N; Tsubota, M; Yamaoka, S; Yoshida, S | 1 |
| Jeong, KS; Lim, SM; Pae, AN; Son, WS | 1 |
| Wang, J; Wang, XW; Yin, CP; Yue, SW; Zhang, Y | 1 |
| Kumamoto, N; Shibata, Y; Shimada, S; Ueda, T; Ugawa, S; Watanabe, M | 1 |
| Chang, YF; Chen, YL; Cheng, JK; Hung, YC; Lin, CS; Shiue, SJ; Tsaur, ML; Wang, SW; Wang, TY; Wang, YC | 1 |
| Chen, ZX; Li, H; Liang, H; Wen, XJ; Xu, SY; Yang, CX | 1 |
| Aoki, Y; Kawabata, A; Maeda, Y; Mitani, K; Nishikawa, H; Okubo, K; Sekiguchi, F; Takahashi, T | 1 |
| Liu, L; Liu, Z; Shu, B; Yue, J; Zhang, Y | 1 |
| Dogrul, A; Gardell, LR; Lai, J; Ossipov, MH; Porreca, F; Tulunay, FC | 1 |
13 other study(ies) available for mibefradil and Nerve Pain
| Article | Year |
|---|---|
Synthesis and T-type calcium channel blocking activity of novel diphenylpiperazine compounds, and evaluation of in vivo analgesic activity.
Topics: Analgesics; Animals; Calcium Channels, T-Type; Humans; Neuralgia; Pain Measurement; Piperazines; Rats | 2010 |
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Hyperalgesia; Inhibitory Concentration 50; Ligands; Mibefradil; Molecular Structure; Molecular Targeted Therapy; Neuralgia; Patch-Clamp Techniques; Piperidines; Quantitative Structure-Activity Relationship; Rats; Spinal Nerves; Structure-Activity Relationship | 2011 |
Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Chemistry Techniques, Synthetic; Drug Stability; Humans; Neuralgia; Rats; Sulfonamides | 2016 |
Synthesis and evaluation of 6-pyrazoylamido-3N-substituted azabicyclo[3,1,0]hexane derivatives as T-type calcium channel inhibitors for treatment of neuropathic pain.
Topics: Administration, Oral; Animals; Azabicyclo Compounds; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; HEK293 Cells; Humans; Male; Neuralgia; Pyrazoles; Rats; Structure-Activity Relationship | 2016 |
Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.
Topics: Action Potentials; Analgesics; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Disease Models, Animal; Drug Design; Flavonoids; HEK293 Cells; Humans; Inhibitory Concentration 50; Male; Mice; Neuralgia; Patch-Clamp Techniques; Structure-Activity Relationship | 2018 |
Structural hybridization of pyrrolidine-based T-type calcium channel inhibitors and exploration of their analgesic effects in a neuropathic pain model.
Topics: Analgesics; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Calcium Signaling; Disease Models, Animal; Gabapentin; Ganglia, Spinal; Humans; Ligation; Microsomes, Liver; Molecular Structure; Neuralgia; Pyrrolidines; Rats; Structure-Activity Relationship | 2019 |
Ca(2+) influx mediates the TRPV4-NO pathway in neuropathic hyperalgesia following chronic compression of the dorsal root ganglion.
Topics: Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Ganglia, Spinal; Hyperalgesia; Male; Mibefradil; Nerve Compression Syndromes; Neuralgia; NF-kappa B; Nitric Oxide; Phorbols; Rats, Wistar; RNA, Small Interfering; Signal Transduction; TRPV Cation Channels | 2015 |
Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
Topics: Analgesics; Animals; Benzimidazoles; Calcium Channels, T-Type; Cyclopropanes; Ganglia, Spinal; Hyperalgesia; Inflammation; Mibefradil; Mice; Naphthalenes; Neuralgia; Neurons | 2015 |
Chronic intrathecal infusion of mibefradil, ethosuximide and nickel attenuates nerve ligation-induced pain in rats.
Topics: Animals; Anticonvulsants; Calcium Channel Blockers; Disease Models, Animal; Ethosuximide; Ligation; Male; Mibefradil; Neuralgia; Nickel; Rats; Rats, Sprague-Dawley | 2015 |
The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Topics: Animals; Behavior, Animal; Calcium Channel Blockers; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression Regulation; Hot Temperature; Hyperalgesia; Lumbar Vertebrae; Male; Mibefradil; Nerve Compression Syndromes; Neuralgia; Protein Isoforms; Random Allocation; Rats; Rats, Sprague-Dawley; Reaction Time; RNA, Messenger; Time Factors; Touch | 2010 |
Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain.
Topics: Animals; Blotting, Western; Calcium Channel Blockers; Calcium Channels, T-Type; Hydrogen Sulfide; Hyperalgesia; Immunohistochemistry; Male; Mibefradil; Neuralgia; Neurons, Afferent; Pain Threshold; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Spinal Nerves; Up-Regulation | 2010 |
Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Ganglia, Spinal; Injections, Spinal; Lumbar Vertebrae; Male; Membrane Potentials; Mibefradil; Neuralgia; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensory Receptor Cells; Spinal Nerves; Up-Regulation | 2013 |
Reversal of experimental neuropathic pain by T-type calcium channel blockers.
Topics: Administration, Topical; Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Dose-Response Relationship, Drug; Ethosuximide; Foot; Hot Temperature; Injections, Intraperitoneal; Injections, Spinal; Ligation; Male; Mibefradil; Neuralgia; Rats; Rats, Sprague-Dawley; Spinal Nerves; Touch; Wounds, Nonpenetrating | 2003 |